Global Brain Tumor Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 681874
  • |
  • Publishe Date : 13-Nov-18
  • |
  • No of Pages: 117
  • |
  • Publisher : Global Info Research

A brain tumor occurs when abnormal cells form within the brain.

Scope of the Report:
This report studies the Brain Tumor Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Brain Tumor Therapeutics market by product type and applications/end industries.
North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing geriatric population.
The global Brain Tumor Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Brain Tumor Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
Pfizer
Novartis
Roche
Merck
AstraZeneca
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
DelMar Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Immunotherapy

Market Segment by Applications, can be divided into
Hospitals
Oncology Treatment Centers
Others

Table of Contents

1 Brain Tumor Therapeutics Market Overview
1.1 Product Overview and Scope of Brain Tumor Therapeutics
1.2 Classification of Brain Tumor Therapeutics by Types
1.2.1 Global Brain Tumor Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Brain Tumor Therapeutics Revenue Market Share by Types in 2017
1.2.3 Surgery
1.2.4 Radiation Therapy
1.2.5 Targeted Therapy
1.2.6 Chemotherapy
1.2.7 Immunotherapy
1.3 Global Brain Tumor Therapeutics Market by Application
1.3.1 Global Brain Tumor Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Oncology Treatment Centers
1.3.4 Others
1.4 Global Brain Tumor Therapeutics Market by Regions
1.4.1 Global Brain Tumor Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Brain Tumor Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Brain Tumor Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Brain Tumor Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Brain Tumor Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Brain Tumor Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Brain Tumor Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Brain Tumor Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Brain Tumor Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
2.3.1 Business Overview
2.3.2 Brain Tumor Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Brain Tumor Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Brain Tumor Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 GE Healthcare
2.6.1 Business Overview
2.6.2 Brain Tumor Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GE Healthcare Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hitachi Medical
2.7.1 Business Overview
2.7.2 Brain Tumor Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hitachi Medical Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Philips Healthcare
2.8.1 Business Overview
2.8.2 Brain Tumor Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Philips Healthcare Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novocure
2.9.1 Business Overview
2.9.2 Brain Tumor Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novocure Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 DelMar Pharmaceuticals
2.10.1 Business Overview
2.10.2 Brain Tumor Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 DelMar Pharmaceuticals Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Brain Tumor Therapeutics Market Competition, by Players
3.1 Global Brain Tumor Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Brain Tumor Therapeutics Players Market Share
3.2.2 Top 10 Brain Tumor Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Brain Tumor Therapeutics Market Size by Regions
4.1 Global Brain Tumor Therapeutics Revenue and Market Share by Regions
4.2 North America Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Brain Tumor Therapeutics Revenue by Countries
5.1 North America Brain Tumor Therapeutics Revenue by Countries (2013-2018)
5.2 USA Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Brain Tumor Therapeutics Revenue by Countries
6.1 Europe Brain Tumor Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Brain Tumor Therapeutics Revenue by Countries
7.1 Asia-Pacific Brain Tumor Therapeutics Revenue by Countries (2013-2018)
7.2 China Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Brain Tumor Therapeutics Revenue by Countries
8.1 South America Brain Tumor Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Brain Tumor Therapeutics by Countries
9.1 Middle East and Africa Brain Tumor Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Brain Tumor Therapeutics Market Segment by Type
10.1 Global Brain Tumor Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Brain Tumor Therapeutics Market Forecast by Type (2018-2023)
10.3 Surgery Revenue Growth Rate (2013-2023)
10.4 Radiation Therapy Revenue Growth Rate (2013-2023)
10.5 Targeted Therapy Revenue Growth Rate (2013-2023)
10.6 Chemotherapy Revenue Growth Rate (2013-2023)
10.7 Immunotherapy Revenue Growth Rate (2013-2023)
11 Global Brain Tumor Therapeutics Market Segment by Application
11.1 Global Brain Tumor Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Brain Tumor Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Oncology Treatment Centers Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Brain Tumor Therapeutics Market Size Forecast (2018-2023)
12.1 Global Brain Tumor Therapeutics Market Size Forecast (2018-2023)
12.2 Global Brain Tumor Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Brain Tumor Therapeutics Picture
Table Product Specifications of Brain Tumor Therapeutics
Table Global Brain Tumor Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Brain Tumor Therapeutics Revenue Market Share by Types in 2017
Figure Surgery Picture
Figure Radiation Therapy Picture
Figure Targeted Therapy Picture
Figure Chemotherapy Picture
Figure Immunotherapy Picture
Table Global Brain Tumor Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Brain Tumor Therapeutics Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Oncology Treatment Centers Picture
Figure Others Picture
Table Global Market Brain Tumor Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Brain Tumor Therapeutics Type and Applications
Table Pfizer Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Brain Tumor Therapeutics Type and Applications
Table Novartis Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Brain Tumor Therapeutics Type and Applications
Table Roche Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Brain Tumor Therapeutics Type and Applications
Table Merck Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Brain Tumor Therapeutics Type and Applications
Table AstraZeneca Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Brain Tumor Therapeutics Type and Applications
Table GE Healthcare Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Hitachi Medical Basic Information, Manufacturing Base and Competitors
Table Hitachi Medical Brain Tumor Therapeutics Type and Applications
Table Hitachi Medical Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Philips Healthcare Basic Information, Manufacturing Base and Competitors
Table Philips Healthcare Brain Tumor Therapeutics Type and Applications
Table Philips Healthcare Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Novocure Basic Information, Manufacturing Base and Competitors
Table Novocure Brain Tumor Therapeutics Type and Applications
Table Novocure Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table DelMar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table DelMar Pharmaceuticals Brain Tumor Therapeutics Type and Applications
Table DelMar Pharmaceuticals Brain Tumor Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Brain Tumor Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Brain Tumor Therapeutics Revenue Share by Players (2013-2018)
Figure Global Brain Tumor Therapeutics Revenue Share by Players in 2016
Figure Global Brain Tumor Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Brain Tumor Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Brain Tumor Therapeutics Revenue Market Share in 2017
Figure Global Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Brain Tumor Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Brain Tumor Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Brain Tumor Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Brain Tumor Therapeutics Revenue Market Share by Regions in 2017
Figure North America Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Brain Tumor Therapeutics Revenue by Countries (2013-2018)
Table North America Brain Tumor Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Brain Tumor Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Brain Tumor Therapeutics Revenue Market Share by Countries in 2017
Figure USA Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Brain Tumor Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Brain Tumor Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Brain Tumor Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Brain Tumor Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Brain Tumor Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Brain Tumor Therapeutics Revenue Market Share by Countries in 2017
Figure China Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Brain Tumor Therapeutics Revenue by Countries (2013-2018)
Table South America Brain Tumor Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Brain Tumor Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Brain Tumor Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Brain Tumor Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Brain Tumor Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Brain Tumor Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Brain Tumor Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Brain Tumor Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Brain Tumor Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Brain Tumor Therapeutics Revenue Share by Type (2013-2018)
Figure Global Brain Tumor Therapeutics Revenue Share by Type (2013-2018)
Figure Global Brain Tumor Therapeutics Revenue Share by Type in 2017
Table Global Brain Tumor Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Brain Tumor Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Surgery Revenue Growth Rate (2013-2018)
Figure Global Radiation Therapy Revenue Growth Rate (2013-2018)
Figure Global Targeted Therapy Revenue Growth Rate (2013-2018)
Figure Global Chemotherapy Revenue Growth Rate (2013-2018)
Figure Global Immunotherapy Revenue Growth Rate (2013-2018)
Table Global Brain Tumor Therapeutics Revenue by Application (2013-2018)
Table Global Brain Tumor Therapeutics Revenue Share by Application (2013-2018)
Figure Global Brain Tumor Therapeutics Revenue Share by Application (2013-2018)
Figure Global Brain Tumor Therapeutics Revenue Share by Application in 2017
Table Global Brain Tumor Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Brain Tumor Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Oncology Treatment Centers Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Brain Tumor Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Brain Tumor Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Brain Tumor Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Brain Tumor Therapeutics Revenue Market Forecast (2018-2023)

Choose License Type